LBA45 First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study)
Ascierto, P.A., Mandala, M., Ferrucci, P.F., Rutkowski, P., Guidoboni, M., Fernandez, A.M. Arance, Ferraresi, V., Maiello, E., Guida, M., Del Vecchio, M., Fierro, M.T., Queirolo, P., Lebbé, C., HelgaVolume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.2275
Date:
September, 2020
File:
PDF, 103 KB
2020